Controversy in Prostate Cancer Screening

The US Preventive Services Task Force ignited a firestorm of controversy within the medical community by announcing that the PSA (prostate specific antigen) blood test should no longer be recommended as a routine screening tool for detection of prostate cancer. However, many patient advocacy groups and physicians disagree with the proposed guideline change. Citing 5 […]